Comparison of novel delivery systems for antisense peptide nucleic acids

被引:33
作者
Chiarantini, L
Cerasi, A
Fraternale, A
Millo, E
Benatti, U
Sparnacci, K
Laus, M
Ballestri, M
Tondelli, L
机构
[1] Univ Urbino, Inst Biochem Giorgio Fornaini, I-61029 Urbino, Italy
[2] Ist Giannina Gaslini, I-16148 Genoa, Italy
[3] Univ Genoa, Dept Expt Med, Biochem Sect, Genoa, Italy
[4] CNR, Inst ORgan Synth & Photoreact, I-40126 Bologna, Italy
关键词
NITRIC-OXIDE SYNTHASE; CELLULAR DELIVERY; IN-VIVO; PNA; INHIBITION; STABILITY; CELLS; DEXAMETHASONE; ERYTHROCYTES; PHAGOCYTOSIS;
D O I
10.1016/j.jconrel.2005.09.013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Peptide nucleic acids (PNAs) provide a powerful too] to study the mechanism of transcription and translation, an innovative strategy to regulate target gene expression. They have been successfully used in antisense technology, for their ability to specifically bind to messenger RNA (mRNA) targets and to inhibit translation of the target genes. However, unlike most of the DNA and RNA oligonucleotides, PNAs are poorly penetrated through the cell membrane, partially due to their uncharged property. To enhance the efficiency in PNA delivery, many strategies have been explored. We here compare the efficacy of three different delivery strategies for antisense PNA: 1) conjugation to hydrophobic peptides, 2) adsorption onto polymeric microspheres and 3) encapsulation in autologous erythrocytes. To this purpose, we designed and prepared PNA sequences able to inhibit the expression of macrophage enzymes involved in inflammatory process, i.e. nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) and tested their antisense activity in a murine macrophage cellular model. Both delivery through polymeric microspheres and encapsulation into erythrocytes allowed the antisense activity of unmodified PNAs at nanomolar concentration. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 36
页数:13
相关论文
共 30 条
[1]   PEPTIDE NUCLEIC-ACIDS AND THEIR POTENTIAL APPLICATIONS IN BIOTECHNOLOGY [J].
BUCHARDT, O ;
EGHOLM, M ;
BERG, RH ;
NIELSEN, PE .
TRENDS IN BIOTECHNOLOGY, 1993, 11 (09) :384-386
[2]   Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application [J].
Caputo, A ;
Brocca-Cofano, E ;
Castaldello, A ;
De Michele, R ;
Altavilla, G ;
Marchisio, M ;
Gavioli, R ;
Rolen, U ;
Chiarantini, L ;
Cerasi, A ;
Dominici, S ;
Magnani, M ;
Cafaro, A ;
Sparnacci, K ;
Laus, M ;
Tondelli, L ;
Ensoli, B .
VACCINE, 2004, 22 (21-22) :2910-2924
[3]   Inhibition of macrophage NOS by selective targeting of antisense PNA [J].
Chiarantini, L ;
Cerasi, A ;
Fraternale, A ;
Andreoni, F ;
Scarí, S ;
Giovine, M ;
Clavarino, E ;
Magnani, M .
BIOCHEMISTRY, 2002, 41 (26) :8471-8477
[4]   MODULATED RED-BLOOD-CELL SURVIVAL BY MEMBRANE-PROTEIN CLUSTERING [J].
CHIARANTINI, L ;
ROSSI, L ;
FRATERNALE, A ;
MAGNANI, M .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 144 (01) :53-59
[5]   PNA HYBRIDIZES TO COMPLEMENTARY OLIGONUCLEOTIDES OBEYING THE WATSON-CRICK HYDROGEN-BONDING RULES [J].
EGHOLM, M ;
BUCHARDT, O ;
CHRISTENSEN, L ;
BEHRENS, C ;
FREIER, SM ;
DRIVER, DA ;
BERG, RH ;
KIM, SK ;
NORDEN, B ;
NIELSEN, PE .
NATURE, 1993, 365 (6446) :566-568
[6]  
ENSOLI B, 2003, Patent No. 0326524
[7]   PNA nucleic acid complexes. Structure, stability and dynamics [J].
Eriksson, M ;
Nielsen, PE .
QUARTERLY REVIEWS OF BIOPHYSICS, 1996, 29 (04) :369-394
[8]   Antisense inhibition of δ-opioid receptor gene function in vivo by peptide nucleic acids [J].
Fraser, GL ;
Holmgren, J ;
Clarke, PBS ;
Wahlestedt, C .
MOLECULAR PHARMACOLOGY, 2000, 57 (04) :725-731
[9]   Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model [J].
Fraternale, A ;
Casabianca, A ;
Orlandi, C ;
Cerasi, A ;
Chiarantini, L ;
Brandi, G ;
Magnani, M .
ANTIVIRAL RESEARCH, 2002, 56 (03) :263-272
[10]   A formula for thermal stability (Tm) prediction of PNA/DNA duplexes [J].
Giesen, U ;
Kleider, W ;
Berding, C ;
Geiger, A ;
Orum, H ;
Nielsen, PE .
NUCLEIC ACIDS RESEARCH, 1998, 26 (21) :5004-5006